Which has grown faster, NAGE or RNAC?

Over the past five years, NAGE grew revenue faster — NAGE at a 15.80% CAGR versus RNAC at -50.01%.

Is NAGE or RNAC more profitable?

NAGE runs the higher net margin — NAGE at 12.39% versus RNAC at -10422.48%.

How have NAGE and RNAC total returns compared?

Over the past 10 years, NAGE delivered -1.06% and RNAC delivered -33.65% annualized total return. Past performance doesn't predict future results.

Niagen Bioscience Inc (NAGE) vs Cartesian Therapeutics, Inc. (RNAC)

A side-by-side comparison of Niagen Bioscience Inc and Cartesian Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

NAGE

Niagen Bioscience Inc

$214M

$2.69HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

RNAC

Cartesian Therapeutics, Inc.

$198M

$6.75HealthcareDelayed quote: Oct 6, 2026, 4:00 PM EDT

Total return — NAGE vs RNAC

growth of $100 · dividends reinvested · last 10y

NAGE -10.1% (-1.1%/yr)RNAC -98.4% (-33.9%/yr)NAGE compounded faster over this window

Log scale — wide-divergence pair

NAGE RNAC

NAGE vs RNAC: by the numbers

•NAGE is the larger company ($214M vs $198M market cap).
•NAGE is profitable (12.39% net margin) while RNAC runs a net loss (-10422.48%).
•NAGE grew revenue faster over the past five years (15.80% vs -50.01% CAGR).

Metrics side by side

Valuation

Metric	NAGE	RNAC
P/E ratio	14.43	N/A
Forward P/E	18.65	N/A
P/S ratio	1.66	134.28
P/B ratio	2.60	N/A
EV / EBITDA	14.36	N/A
FCF yield	2.65%	N/A

Profitability

Metric	NAGE	RNAC
Gross margin	64.24%	100.00%
Operating margin	6.67%	-3099.93%
Net margin	12.39%	-10422.48%
ROE	19.38%	N/A
ROIC	8.84%	-33.10%

Growth (annualized)

Metric	NAGE	RNAC
Revenue CAGR (5Y)	15.80%	-50.01%
Total return CAGR (5Y)	-15.72%	-44.03%

Frequently asked

Which has grown faster, NAGE or RNAC?: Over the past five years, NAGE grew revenue faster — NAGE at a 15.80% CAGR versus RNAC at -50.01%.
Is NAGE or RNAC more profitable?: NAGE runs the higher net margin — NAGE at 12.39% versus RNAC at -10422.48%.
How have NAGE and RNAC total returns compared?: Over the past 10 years, NAGE delivered -1.06% and RNAC delivered -33.65% annualized total return. Past performance doesn't predict future results.

Go deeper

Full NAGE analysis Full RNAC analysis Interactive comparison tool

Dig into the metrics

Niagen Bioscience P/E ratio Niagen Bioscience ROE Cartesian Therapeutics ROE Niagen Bioscience operating margin Cartesian Therapeutics operating margin Niagen Bioscience revenue growth Cartesian Therapeutics revenue growth Niagen Bioscience free cash flow Cartesian Therapeutics free cash flow

Niagen Bioscience & Cartesian Therapeutics appear in these rankings

Fastest Revenue Growth Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.